The real Oshtoran Syndrome. Also known as H63D Syndrome Type-3 or Spider Man Disease
Par :Formats :
Disponible dans votre compte client Decitre ou Furet du Nord dès validation de votre commande. Le format ePub est :
- Compatible avec une lecture sur My Vivlio (smartphone, tablette, ordinateur)
- Compatible avec une lecture sur liseuses Vivlio
- Pour les liseuses autres que Vivlio, vous devez utiliser le logiciel Adobe Digital Edition. Non compatible avec la lecture sur les liseuses Kindle, Remarkable et Sony
, qui est-ce ?Notre partenaire de plateforme de lecture numérique où vous retrouverez l'ensemble de vos ebooks gratuitement
Pour en savoir plus sur nos ebooks, consultez notre aide en ligne ici
C'est si simple ! Lisez votre ebook avec l'app Vivlio sur votre tablette, mobile ou ordinateur :
- Nombre de pages28
- FormatePub
- ISBN978-3-7583-8676-3
- EAN9783758386763
- Date de parution12/10/2023
- Protection num.Digital Watermarking
- Taille68 Ko
- Infos supplémentairesepub
- ÉditeurBooks on Demand
Résumé
In a whirlwind collision of medical science and pop culture, Oshtoran Syndrome uncovers a medical enigma that defies conventions. First unearthed by the Zafarian brothers in Iran and later propelled into the limelight by the Adams Group, this puzzling disorder finds its guardianship under the esteemed International H63D Mutation Syndrome Research Consortium. Spearheaded by Chairman Riku Honda and his unwavering Vice Chairman Dr.
Rocha, the consortium embarks on a scientific odyssey to demystify the condition. Mired in academic controversies, entangled with the MARVEL entertainment use of the illness for their Spider-Man storyline, and burdened by the exigencies of clinical relevancy, Oshtoran Syndrome represents an uncharted territory in medical science. With rigorous academic frameworks and an overwhelming global response, the H63D Syndrome Research Consortium vows to undertake the monumental task ahead.
Witness a journey through the labyrinth of rare diseases where politics, ethics, the entertainment industry and hard medical science converge, shaping the future of medical research.
Rocha, the consortium embarks on a scientific odyssey to demystify the condition. Mired in academic controversies, entangled with the MARVEL entertainment use of the illness for their Spider-Man storyline, and burdened by the exigencies of clinical relevancy, Oshtoran Syndrome represents an uncharted territory in medical science. With rigorous academic frameworks and an overwhelming global response, the H63D Syndrome Research Consortium vows to undertake the monumental task ahead.
Witness a journey through the labyrinth of rare diseases where politics, ethics, the entertainment industry and hard medical science converge, shaping the future of medical research.
In a whirlwind collision of medical science and pop culture, Oshtoran Syndrome uncovers a medical enigma that defies conventions. First unearthed by the Zafarian brothers in Iran and later propelled into the limelight by the Adams Group, this puzzling disorder finds its guardianship under the esteemed International H63D Mutation Syndrome Research Consortium. Spearheaded by Chairman Riku Honda and his unwavering Vice Chairman Dr.
Rocha, the consortium embarks on a scientific odyssey to demystify the condition. Mired in academic controversies, entangled with the MARVEL entertainment use of the illness for their Spider-Man storyline, and burdened by the exigencies of clinical relevancy, Oshtoran Syndrome represents an uncharted territory in medical science. With rigorous academic frameworks and an overwhelming global response, the H63D Syndrome Research Consortium vows to undertake the monumental task ahead.
Witness a journey through the labyrinth of rare diseases where politics, ethics, the entertainment industry and hard medical science converge, shaping the future of medical research.
Rocha, the consortium embarks on a scientific odyssey to demystify the condition. Mired in academic controversies, entangled with the MARVEL entertainment use of the illness for their Spider-Man storyline, and burdened by the exigencies of clinical relevancy, Oshtoran Syndrome represents an uncharted territory in medical science. With rigorous academic frameworks and an overwhelming global response, the H63D Syndrome Research Consortium vows to undertake the monumental task ahead.
Witness a journey through the labyrinth of rare diseases where politics, ethics, the entertainment industry and hard medical science converge, shaping the future of medical research.